Vitamin K prophylaxis in the Newborn
Research type
Research Study
Full title
Vitamin K prophylaxis in the Newborn: Exploring parents’ understanding using a mixed method approach
IRAS ID
370575
Contact name
Vrinda Nair
Contact email
Sponsor organisation
R&D Department, Tees Valley Research Alliance
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
Vitamin K is routinely given to all newborn babies to help protect them against bleeding, especially bleeding into the brain. An increasing number of families are choosing to decline vitamin K injections or choose vitamin K drops which can be less effective. This study will explore parents’ understanding of giving Vitamin K injections to newborn babies, and why some parents choose to decline vitamin K even after speaking with their baby’s health professional. Anonymous information will be collected through surveys which will be sent to all parents who are 35 weeks of more, as well as carrying out interviews with any parent who has given birth and chosen vitamin K drops or declined the Vitamin K injection. Interviews will be carried out on Microsoft teams or over the phone. Qualitative data will from the interview and survey will be analysed through thematic analysis.
REC name
London - Bromley Research Ethics Committee
REC reference
26/LO/0483
Date of REC Opinion
24 Jun 2026
REC opinion
Unfavourable Opinion